PHIO Insider Trading

Insider Ownership Percentage: 0.77%
Insider Buying (Last 12 Months): $10,726.00
Insider Selling (Last 12 Months): $0.00

Phio Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Phio Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Phio Pharmaceuticals Share Price & Price History

Current Price: $0.87
Price Change: Price Decrease of -0.08 (-8.40%)
As of 11/28/2023 01:00 AM ET

This chart shows the closing price history over time for PHIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Phio Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/30/2023Robert J BittermanCEOBuy1,000$2.88$2,880.0018,211View SEC Filing Icon  
6/14/2023Robert L FerraraDirectorBuy2,000$3.10$6,200.006,000View SEC Filing Icon  
12/14/2022Robert J BittermanChairmanBuy2,000$0.39$780.0074,541View SEC Filing Icon  
12/7/2022Robert J BittermanChairmanBuy2,000$0.39$780.0072,541View SEC Filing Icon  
11/29/2022Robert J BittermanChairmanBuy215$0.40$86.0068,541View SEC Filing Icon  
11/25/2022Robert J BittermanChairmanBuy2,500$0.42$1,050.0068,326View SEC Filing Icon  
11/23/2022Robert L FerraraDirectorBuy2,000$0.41$820.0025,000View SEC Filing Icon  
11/16/2022Robert J BittermanChairmanBuy1$1,750.00$1,750.001View SEC Filing Icon  
8/16/2021Gerrit DispersynCEOBuy6,000$1.63$9,780.00View SEC Filing Icon  
3/3/2021Gerrit DispersynCEOBuy2,500$3.03$7,575.00View SEC Filing Icon  
3/3/2021Robert L. FerraraDirectorBuy682$3.15$2,148.30View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Phio Pharmaceuticals (NASDAQ:PHIO)

12.38% of Phio Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PHIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Phio Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2023Anson Funds Management LP22,571$65K0.0%N/A1.505%Search for SEC Filing on Google Icon
8/10/2023Cetera Investment Advisers10,666$31K0.0%N/A0.711%Search for SEC Filing on Google Icon
8/2/2023Bank of Montreal Can10,000$38K0.0%N/A0.667%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC14,280$80K0.0%-91.4%1.241%Search for SEC Filing on Google Icon
5/11/2023Cambridge Investment Research Advisors Inc.14,233$80K0.0%N/A1.237%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC166,800$62K0.0%-21.9%14.632%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.218,192$0.13M0.0%-26.8%1.596%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC213,600$0.12M0.0%-9.0%1.564%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC234,849$0.17M0.0%+465.9%1.719%Search for SEC Filing on Google Icon
8/11/2022Cetera Investment Advisers75,000$53K0.0%-16.7%0.549%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC41,500$37K0.0%+310.9%0.304%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.304,119$0.27M0.0%+6.8%2.226%Search for SEC Filing on Google Icon
5/13/2022Cetera Investment Advisers90,000$80K0.0%+125.0%0.659%Search for SEC Filing on Google Icon
11/16/2021Cetera Investment Advisers30,000$61K0.0%N/A0.222%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.35,592$72K0.0%-17.8%0.263%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC27,110$61K0.0%+74.7%0.200%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.276,561$0.63M0.0%+125.4%2.043%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP23,960$54K0.0%-31.2%0.177%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC15,522$42K0.0%N/A0.115%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP34,808$93K0.0%+38.3%0.257%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC87,501$0.23M0.0%+330.6%0.647%Search for SEC Filing on Google Icon
5/10/2021GSA Capital Partners LLP132,333$0.36M0.1%+30.5%0.978%Search for SEC Filing on Google Icon
3/26/2021Susquehanna International Group LLP12,058$32K0.0%N/A0.085%Search for SEC Filing on Google Icon
3/8/2021Dimensional Fund Advisors LP25,177$68K0.0%N/A0.178%Search for SEC Filing on Google Icon
2/25/2021Dimensional Fund Advisors LP25,177$68K0.0%N/A0.178%Search for SEC Filing on Google Icon
2/4/2021GSA Capital Partners LLP101,401$0.27M0.0%+376.6%1.754%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC35,929$77K0.0%N/A0.622%Search for SEC Filing on Google Icon
11/6/2020GSA Capital Partners LLP21,278$46K0.0%N/A0.368%Search for SEC Filing on Google Icon
7/16/2020Wedbush Securities Inc.33,374$73K0.0%N/A0.577%Search for SEC Filing on Google Icon
5/15/2020Sabby Management LLC255,194$0.45M0.2%N/A8.901%Search for SEC Filing on Google Icon
5/12/2020JPMorgan Chase & Co.21,681$38K0.0%N/A0.755%Search for SEC Filing on Google Icon
2/14/2020UBS Group AG45,409$0.43M0.0%+43.3%6.997%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC333,890$57K0.0%+585.9%51.447%Search for SEC Filing on Google Icon
1/28/2020SG Americas Securities LLC792,374$0.14M0.0%+12.3%121.904%Search for SEC Filing on Google Icon
11/4/2019SG Americas Securities LLC705,353$0.19M0.0%+16.9%2.756%Search for SEC Filing on Google Icon
8/16/2019CVI Holdings LLC406,358$0.15M0.1%-32.8%1.701%Search for SEC Filing on Google Icon
8/14/2019Citadel Advisors LLC85,621$33K0.0%+148.9%0.358%Search for SEC Filing on Google Icon
6/30/2019SG Americas Securities LLC603,528$0.23M0.0%+163.8%2.526%Search for SEC Filing on Google Icon
4/29/2019SG Americas Securities LLC228,825$0.10M0.0%+39.8%1.026%Search for SEC Filing on Google Icon
4/12/2019Virtu Financial LLC238,544$0.11M0.0%N/A1.070%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Phio Pharmaceuticals logo
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. The company develops PH-762, INTASYL compound which reduces the expression of cell death Protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; PH-894 that silences the BRD4, a protein which controls gene expression in both T cells and tumor cells, effecting the immune system as well as the tumor; and PH-804 that targets the TIGIT, a protein which inhibits the activity of Natural Killer cells. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.
Read More on Phio Pharmaceuticals

Today's Range

Now: $0.87
Low: $0.87
High: $1.01

50 Day Range

MA: $1.29
Low: $0.87
High: $2.60

52 Week Range

Now: $0.87
Low: $0.88
High: $12.27

Volume

33,621 shs

Average Volume

58,693 shs

Market Capitalization

$2.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.33

Who are the company insiders with the largest holdings of Phio Pharmaceuticals?

Phio Pharmaceuticals' top insider shareholders include:
  1. Robert J Bitterman (Chairman)
  2. Robert L Ferrara (Director)
  3. Robert J Bitterman (CEO)
Learn More about top insider investors at Phio Pharmaceuticals.

Who are the major institutional investors of Phio Pharmaceuticals?

Phio Pharmaceuticals' top institutional investors include:
  1. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Phio Pharmaceuticals stock.